Synchronous Occurrence of Glioblastoma Multiforme and Esophageal Adenocarcinoma

Beech, Derrick J.; Madan, Atul K.; Aliabadi-Wahle, Shaghayegh; Hays, Angela N.; Long, William P.
February 2003
American Surgeon;Feb2003, Vol. 69 Issue 2, p136
Academic Journal
Case Study
Synchronous malignancies are rare occurrences for which there may be a genetic link between two cancers or which may be simply coincidental. Although glioblastoma multiforme and esophageal adenocarcinoma have few clinical similarities there are no known biochemical or genetic links between the two malignancies. This case discussion details the synchronous occurrences of these two lesions and highlights possible clinical, biochemical, and genetic commonalities.


Related Articles

  • Esophageal Adenocarcinoma Associated with Barrett's Esophagus: Long--term Management with Laser Ablation. Ertan, Atilla; Zimmerman, Michael; Younes, Mamoun // American Journal of Gastroenterology;Dec1995, Vol. 90 Issue 12, p2201 

    We report the use of neodymium:yttrium-aluminum-garnet (Nd:YAG) laser ablation to treat high-grade dysplasia and intramucosal esophageal adenocarcinoma associated with Barrett's esophagus in a patient who refused surgery. Throughout laser therapy, the patient received omeprazole 40 mg/day. After...

  • Continuing Rapid Increase in Esophageal Adenocarcinoma in England and Wales. Lepage, Côme; Rachet, Bernard; Jooste, Valérie; Faivre, Jean; Coleman, Michel P. // American Journal of Gastroenterology;Nov2008, Vol. 103 Issue 11, p2694 

    BACKGROUND AND AIMS: Substantial changes have occurred in the epidemiology of esophageal adenocarcinoma. We examined trends in incidence in a large national population. METHODS: All esophageal adenocarcinomas registered in England and Wales over a 31-year period (1971–2001) were...

  • Tryptophan PET predicts spatial and temporal patterns of post-treatment glioblastoma progression detected by contrast-enhanced MRI. Bosnyák, Edit; Kamson, David; Robinette, Natasha; Barger, Geoffrey; Mittal, Sandeep; Juhász, Csaba // Journal of Neuro-Oncology;Jan2016, Vol. 126 Issue 2, p317 

    Amino acid PET is increasingly utilized for the detection of recurrent gliomas. Increased amino acid uptake is often observed outside the contrast-enhancing brain tumor mass. In this study, we evaluated if non-enhancing PET+ regions could predict spatial and temporal patterns of subsequent MRI...

  • Prevalence of Barrett's esophagus and expression of mucin antigens detected by a panel of monoclonal antibodies in Barrett's esophagus and esophageal adenocarcinoma in Japan. Azuma, Naoki; Endo, Takao; Arimura, Yoshiaki; Motoya, Satoshi; Itoh, Fumio; Hinoda, Yuji; Irimura, Tatsuro; Hosokawa, Masao; Imai, Kohzoh; Azuma, N; Endo, T; Arimura, Y; Motoya, S; Itoh, F; Hinoda, Y; Irimura, T; Hosokawa, M; Imai, K // Journal of Gastroenterology;2000, Vol. 35 Issue 8, p583 

    Barrett's esophagus (BE) is an acquired disorder associated with a high incidence of adenocarcinoma of the lower esophagus. Moreover, it has been reported that short-segment BE may be associated with adenocarcinoma of the esophagogastric junction. The objective of this study was to define the...

  • Leukotriene A[sub 4] Hydrolase in Rat and Human Esophageal Adenocarcinomas and Inhibitory Effects of Bestatin. Xiaoxin Chen; Ning Li; Shah, Keerti V.; Anastos, Kathryn; Klein, Robert S.; Minkoff, Howard; Duerr, Ann; Massad, L. Stewart; Celentano, David D.; Hall, Charles; Fazzari, Melissa; Cu-Uvin, Susan; Bacon, Melanie; Schuman, Paula; Levine, Alexandra M.; Durante, Amanda J.; Gange, Stephen; Melnick, Sandra; Burk, Robert D. // JNCI: Journal of the National Cancer Institute;7/16/2003, Vol. 95 Issue 14, p1053 

    Background.' Esophageal adenocarcinoma (EAC) is increasing at the most rapid rate of any cancer in the United States. An esophagogastroduodenal anastomosis (EGDA) surgical model in rats mimics human gastroesophageal reflux and results in EAC. Leukotriene A[sub 4] hydrolase (LTA[sub 4]H), a...

  • SWOG S0356: Combination therapy failed to meet endpoint in esophageal adenocarcinoma.  // Hem/Onc Today;11/25/2011, Vol. 12 Issue 22, p9 

    The article presents a study that examined the pathologic complete response of the SWOG S0356 combination treatment for patients with esophageal adenocarcinoma.

  • Carcinoma of the oesophagus. Seitz, J F; Sarradet, A; François, E; Jacob, J H; Ollivier, J M; Rougier, P; Roussel, A // British Journal of Cancer;5/2/2001 Supplement 2, Vol. 84, p61 

    Studies the treatment for adenocarcinoma of esophagus which is the fourth commonest cause of death in France as of May 2, 2001. Histopathological study of biopsies taken by oesophagogastric fibroscopy; Use of radiotherapy and chemotherapy for the surgery.

  • Expression of sulfated carbohydrate chain and core peptides of mucin detected by monoclonal antibodies in Barrett's esophagus and esophageal adenocarcinoma. Endo, Takao; Tamaki, Kazuhiro; Arimura, Yoshiaki; Itoh, Fumio; Hinoda, Yuji; Hareyama, Masato; Irimura, Tatsuro; Fujita, Masahiro; Imai, Kohzoh; Endo, T; Tamaki, K; Arimura, Y; Itoh, F; Hinoda, Y; Hareyama, M; Irimura, T; Fujita, M; Imai, K // Journal of Gastroenterology;1998, Vol. 33 Issue 6, p811 

    Columnar epithelium-lined esophagus (Barrett's esophagus) is an acquired disorder associated with a high incidence of adenocarcinoma of the lower esophagus. Columnar epithelium resembling intestinal metaplasia (IM) is especially important, since it is considered to be a premalignant condition....

  • Correction.  // Gut;Dec2013, Vol. 62 Issue 12, p1820 

    A correction to the article "A global assessment of the oesophageal adenocarcinoma epidemic" that was published in the 2013 issue is presented.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics